Risk analysis of neurological adverse events related to CAR T-cell therapy with brexucabtagene autoleucel based on the US FDA Adverse Event Reporting System

Zhao Na, Ye Xia, Wang Zhiyan, Lu Chao, Hu Fangyuan, Yuan Lei

PDF(497 KB)
PDF(497 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (8) : 454-459. DOI: 10.3760/cma.j.cn114015-20221226-01168

Risk analysis of neurological adverse events related to CAR T-cell therapy with brexucabtagene autoleucel based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(8): 454-459 https://doi.org/10.3760/cma.j.cn114015-20221226-01168

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(497 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉